Scinvivo

Amsterdam, The Netherlands

Scinvivo develops imaging technology that specializes in optical biopsy for bladder cancer diagnostics.

$5.1M raised

Feb 2024

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Scinvivo raised?

Scinvivo has raised $5.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2024.

Who are Scinvivo's investors?

Scinvivo's investors include Innovatiefonds Noord-Holland, NLC, Netherlands Enterprise Agency, Santec Corporation.

Where is Scinvivo headquartered?

Scinvivo is headquartered in Amsterdam, The Netherlands.

What does Scinvivo do?

Scinvivo develops imaging technology that specializes in optical biopsy for bladder cancer diagnostics.

What stage is Scinvivo at?

Scinvivo is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 21, 2024.

MLA

"Scinvivo — Funding & Investors." VCBacked, February 21, 2024, https://www.vcbacked.co/company/scinvivo. Accessed July 2, 2026.

APA

VCBacked. (2024). Scinvivo — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/scinvivo

Wikipedia (cite web)

{{cite web |title=Scinvivo — Funding & Investors |url=https://www.vcbacked.co/company/scinvivo |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 21, 2024.